Clinical Trial Update: A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting

View source ↗

Summary

A clinical trial assessing patient-reported wellbeing in plaque psoriasis using tildrakizumab; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Plaque Psoriasis | Status: ACTIVE_NOT_RECRUITING